Guardant Health
GH
#1557
Rank
โ‚น1.203 T
Marketcap
โ‚น9,269
Share price
-0.57%
Change (1 day)
207.38%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -โ‚น34.36 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น0.90 Billion. In 2024 the company made an earning of -โ‚น39.31 Billion, an increase over its 2023 earnings that were of -โ‚น43.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น34.36 Billion-12.58%
2024 -โ‚น39.31 Billion-9.12%
2023 -โ‚น43.25 Billion-26.73%
2022 -โ‚น59.03 Billion69.96%
2021 -โ‚น34.73 Billion56.35%
2020 -โ‚น22.22 Billion252.69%
2019 -โ‚น6.3 Billion-17.22%
2018 -โ‚น7.61 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Natera
NTRA
-โ‚น28 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-โ‚น96.99 Billion 170.04%๐Ÿ‡บ๐Ÿ‡ธ USA